Patricia Vergara Aragon
National Autonomous University of Mexico, Mexico
Dr. Patricia Vergara Aragon MD has purceived and PhD in Psychological Research and she has worked in the Faculty of Medicine UNAM in Mexico for more than 30 years. She collaborates with the Physics Institute of the National Polytechnique Institute. Her research is focused on the field of Parkinson disease (PD): Study of the nigrostriatal pathway degeneration, and involved mechanism caused by rotenone and 6-OHDA; stabilization of Dopamine and its use as treatment for PD; the study of the effects produced in vivo of a TiO2 amorphous matrix as a reservoir for dopamine in a PD model in rats; description of the cognitive implications of PD in patients; toxicity and biological implications of rotenone exposure in animal models.
Nanomaterials, Dopamine Implants, Parkinsonism, Animal Modelling, Toxicity studies, Nervous System Disorders